
Five things for pharma marketers to know for Thursday, October 23, 2025
A burgeoning probe by the Trump administration into drug pricing could lay the ground for new pharma tariffs. The administration is investigating if any U.S. trading partners have been underpaying for drugs. (Financial Times) Takeda and Innovent from …